Clinical Trial Update: Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury [Phase 1, Phase 2]

View source ↗

Summary

An update on a clinical trial evaluating rosuvastatin's effect on cytokines in traumatic brain injury (Phase 1 and Phase 2). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Universidad Autonoma de San Luis Potosí | Conditions: Head Injury | Phase 1, Phase 2 | Status: COMPLETED